Frazier Life Sciences Management, L.P. Mirum Pharmaceuticals, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.59 Billion
- Q1 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 6,795,121 shares of MIRM stock, worth $343 Million. This represents 19.27% of its overall portfolio holdings.
Number of Shares
6,795,121
Previous 6,570,392
3.42%
Holding current value
$343 Million
Previous $272 Million
12.67%
% of portfolio
19.27%
Previous 16.29%
Shares
8 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Janus Henderson Group PLC London, X04.77MShares$240 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$163 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$141 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$128 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.53MShares$127 Million2.42% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.85B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...